|
⚲
|
| Keyboard |
| Bhat Laxminarayan
✚
|
|
|---|---|
| CIK # | 0001818245 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001818245] | |
| 4 | [0001818245] | |
| SC 13D | [0001818245] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| BHAT Laxminarayan | Reviva Pharmaceuticals Holdings Inc | [2020-12-21] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Bhat Laxminarayan | |
| Reviva Pharmaceuticals Holdings Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Reviva Pharmaceuticals Holdings Inc RVPH
Stock Option (right to buy) · derivative
|
2026-03-18 | Grant | 40,925 | $0.00 | |
|
Reviva Pharmaceuticals Holdings Inc RVPH
Stock Option (right to buy) · derivative
|
2026-03-18 | Grant | 109,150 | $0.00 | |
|
Reviva Pharmaceuticals Holdings Inc RVPH
Stock Option (right to buy) · derivative
|
2025-02-13 | Grant | 181,500 | $0.00 | |
|
Reviva Pharmaceuticals Holdings Inc RVPH
Stock Option (right to buy) · derivative
|
2025-02-13 | Grant | 519,000 | $0.00 | |
|
Reviva Pharmaceuticals Holdings Inc RVPH
Stock Option (right to buy) · derivative
|
2024-09-15 | Grant | 158,451 | $0.00 | |
|
Reviva Pharmaceuticals Holdings Inc RVPH
Stock Option (right to buy) · derivative
|
2024-09-15 | Grant | 77,843 | $0.00 | |
|
Reviva Pharmaceuticals Holdings Inc RVPH
Stock Option (right to buy) · derivative
|
2023-04-25 | Grant | 150,000 | $0.00 | |
|
Reviva Pharmaceuticals Holdings Inc RVPH
Stock Option (right to buy) · derivative
|
2023-04-25 | Grant | 443,000 | $0.00 |